Events and Conferences

Genoskin will participate in the 55th Annual Meeting of the European Society for Dermatological Research, a leading event bringing together scientists, clinicians, and industry experts to discuss advances in skin biology and dermatological research.

Visit us at booth #4 to discover how our human-relevant ex vivo skin models can support dermatology research and therapeutic development. Our team will also present three scientific posters covering scalp inflammation, advanced immune profiling in psoriasis, and age-associated molecular signatures in human skin.

We look forward to connecting with the dermatology research community in Heidelberg.

Genoskin is exhibiting at the EUROTOX conference in Vienna, Austria from September 13th to 16th.

EUROTOX 2026 brings together the global toxicology community to exchange cutting-edge science, explore emerging approaches to toxicology assessment, and connect researchers across academia, industry, and regulatory science.

This conference will be an excellent opportunity to meet our experts and learn how our ex vivo human skin models and translational research solutions can support toxicology, preclinical toxicity testing, and drug development programs with human-relevant data. 

Celebrating its 60th Congress in Vienna, this year’s meeting will embrace the theme “Toxicology without borders”—creating a unique forum for scientific exchange, new perspectives, and collaborations shaping the future of toxicology.

Contact us to schedule a meeting with our colleagues on site or meet us directly at booth #51.

Genoskin showcased how our human-relevant in vitro mast cell models support the study of immune and inflammatory responses, mast cell activation, degranulation, mediator release, and drug candidate evaluation.

The EMBRN’s 12th International Conference is a key international event dedicated to mast cell and basophil biology, immunology, and inflammatory mechanisms.

It was a valuable opportunity for exchange and collaboration with the mast cell, basophil, immunology, and pharmaceutical research communities.

Genoskin was pleased to participate in the MPS World Summit, a leading event focused on microphysiological systems and human-relevant models.

MPS are transforming bioengineering by enabling more predictive, human-based data. As a provider of New Approach Methodologies (NAMs), Genoskin offers ex vivo human skin platforms that complement these approaches by generating immunocompetent data from real human tissue, helping bridge the gap to clinical outcomes.

We were pleased to connect with the MPS community and explore new partnerships. Our team enjoyed discussing how Genoskin can support translational research.

Genoskin was pleased to participate in the Society for Investigative Dermatology (SID) Annual Meeting, a leading forum for cutting-edge research in skin biology and disease.

We were at the event with a booth and two scientific posters to share how our ex vivo human skin platforms deliver biologically relevant, immunocompetent human data to advance dermatological and translational research.

It was a valuable opportunity for scientific exchange, collaboration, and discussion with fellow researchers on the future of human-relevant skin science.

Genoskin was excited to participate in the Society of Toxicology (SOT) Annual Meeting and ToxExpo, the world’s largest gathering of toxicology experts.

We were  at the event with a booth and three scientific posters to share how our ex vivo human skin and mast cell platforms offer relevant human data for assessing immunotoxicity and local tolerance of injectable therapeutics and drug delivery systems.

It was a memorable time of scientific exchange and collaboration!

Genoskin was excited to participate in the American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting, one of the leading global gatherings for experts in allergy and immunology.

We have been on site with a dedicated booth and scientific poster presentation focused on our human primary mast cell portfolio, highlighting its application for studying mast cell activation, degranulation, and immune mechanisms relevant to allergic and inflammatory responses.

It was a pleasure to engage in insightful scientific discussions and connect with experts advancing the field of allergy and immunology.